Skip to main content

Advertisement

Table 3 Median ranks for different types of drugs in the combined evaluation set

From: Towards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypes

Drug type Our approach Hoehndorf’s approach p-value
Non-targeted cancer therapies (chemotherapies) 9.5 % 25.8 % p=0.023
Targeted cancer drugs 7.3 % 56.4 % p=0.015
Non-cancer drugs 13.3 % 67.4 % p=0.0006